ZNF182 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.297100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.863400E-01
Normal-vs-Stage2
4.715700E-03
Normal-vs-Stage3
2.439700E-02
Normal-vs-Stage4
1.736200E-01
Stage1-vs-Stage2
1.123800E-01
Stage1-vs-Stage3
1.915870E-02
Stage1-vs-Stage4
3.331600E-01
Stage2-vs-Stage3
4.773600E-02
Stage2-vs-Stage4
8.028600E-01
Stage3-vs-Stage4
2.784400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.963100E-03
Normal-vs-AfricanAmerican
1.101850E-01
Normal-vs-Asian
1.277990E-02
Caucasian-vs-AfricanAmerican
7.498000E-01
Caucasian-vs-Asian
3.325400E-01
AfricanAmerican-vs-Asian
7.443600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.481500E-03
Normal-vs-Female
9.315900E-03
Male-vs-Female
5.541200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.688200E-01
Normal-vs-Age(41-60Yrs)
2.586400E-02
Normal-vs-Age(61-80Yrs)
3.001000E-03
Normal-vs-Age(81-100Yrs)
1.786950E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.758560E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.665700E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.232800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.164600E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.942900E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.244400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.000700E-03
Normal-vs-Daily Drinker
6.278000E-02
Normal-vs-Weekly Drinker
1.524090E-02
Normal-vs-Occasional Drinker
1.604380E-02
Normal-vs-Social Drinker
1.288650E-01
Non Drinker-vs-Daily Drinker
6.520800E-01
Non Drinker-vs-Weekly Drinker
9.111800E-01
Non Drinker-vs-Occasional Drinker
2.907400E-01
Non Drinker-vs-Social Drinker
4.180300E-02
Daily Drinker-vs-Weekly Drinker
6.635000E-01
Daily Drinker-vs-Occasional Drinker
7.321400E-01
Daily Drinker-vs-Social Drinker
2.639600E-01
Weekly Drinker-vs-Occasional Drinker
3.406800E-01
Weekly Drinker-vs-Social Drinker
9.396000E-02
Occasional Drinker-vs-Social Drinker
2.906600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.234850E-01
Normal-vs-Grade 2
1.272310E-02
Normal-vs-Grade 3
1.976190E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.194000E-01
Grade 1-vs-Grade 3
8.489600E-01
Grade 1-vs-Grade 4
1.234850E-01
Grade 2-vs-Grade 3
2.608600E-01
Grade 2-vs-Grade 4
1.272310E-02
Grade 3-vs-Grade 4
1.976190E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.835800E-03
Normal-vs-NonDiabetic
6.384300E-03
Diabetic-vs-NonDiabetic
3.365400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.490100E-02
Normal-vs-NoPancreatitis
1.342320E-03
Pancreatitis-vs-NoPancreatitis
1.027250E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.751600E-02
Normal-vs-N1
3.337100E-03
N0-vs-N1
9.716600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.447800E-01
Normal-vs-TP53-NonMutant
9.124300E-02
TP53-Mutant-vs-TP53-NonMutant
6.795000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
